Sector: Financials | Industry: Financial & Commodity Market Operators |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 20 S. Wacker Dr. CHICAGO IL 60606 |
Tel: | N/A |
Website: | https://www.cmegroup.com |
IR: | See website |
Key People | ||
Terrence A. Duffy Executive Chairman of the Board, Chief Executive Officer | Kendal Vroman Senior Managing Director - Chief Transformation Officer | Lynne Fitzpatrick Chief Financial Officer |
Julie Holzrichter Chief Operating Officer, Senior Managing Director - Global Operations and CME Clearing | Hilda Harris Piell Chief Human Resource Officer, Senior Managing Director | Jack J. Tobin Chief Accounting Officer, Managing Director |
Sunil K. Cutinho Chief Information Officer | Tim Mccourt Senior Managing Director, Global Head of Equity, FX Products, Rates, Financial and OTC Products | Derek Sammann Senior Managing Director - Global Head of Commodities and Options and International Markets | Suzanne Sprague Senior Managing Director - Global Head of Clearing and Post-Trade Services for CME Group |
Business Overview |
CME Group Inc. provides a derivatives marketplace. The Company enables clients to trade futures, options, cash and over the counter (OTC) markets, optimize portfolios, and analyze data. It exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. It offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates central counterparty clearing provider, CME Clearing. Its products provide a means for hedging, speculation and asset allocation related to the risks associated with, among other things, interest rate sensitive instruments, and changes in the prices of agricultural, energy and metal commodities. It provides clearing and settlement services for a range of exchange-traded futures and options on futures contracts and OTC derivatives. |
Financial Overview |
For the fiscal year ended 31 December 2023, CME Group Inc revenues increased 50% to $10.85B. Net income applicable to common stockholders increased 20% to $3.19B. Revenues reflect Investment Income increase from $2.2B to $5.28B, Clearing and transaction fees increase of 11% to $4.59B, Other Revenue - Balancing value increase of 24% to $316.9M. Net income was partially offset by Other income (expense) increase from $1.86B to $4.69B (expense). |
Employees: | 3,565 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $77,979M as of Dec 31, 2023 |
Annual revenue (TTM): | $10,854M as of Dec 31, 2023 |
EBITDA (TTM): | $9,064M as of Dec 31, 2023 |
Net annual income (TTM): | $3,186M as of Dec 31, 2023 |
Free cash flow (TTM): | $141.90M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $469.50M as of Dec 31, 2023 |
Shares outstanding: | 360,028,355 as of Mar 11, 2024 |
Index Membership: | S&P 500 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |